1. Resources >>
  2. Companies directory >>
  3. Fibrocell Science
Fibrocell Science

Fibrocell Science

Fibrocell is an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. Fibrocell’s most advanced product candidate, FCX-007, is the subject of a Phase 1/2 clinical trial for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). Fibrocell is also developing FCX-013, the Company's clinical stage candidate for the treatment of moderate to severe localized scleroderma. Fibrocell’s gene-therapy portfolio is being developed in collaboration with Precigen, Inc., a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON), a leader in synthetic biology. For more information, visit www.fibrocell.com or follow Fibrocell on Twitter at @Fibrocell.
Headquarters
Exton, PA
Company size
10,001+ employees
Specialties
autologous fibroblast cell therapy, gene therapy, personalized biologics
Top employees at
Fibrocell Science
P
Pam Swiggard
VP, Regulatory Affairs and Quality Assurance
Greater Philadelphia Area
R
Robin Gibson
HR Manager
Coatesville, Pennsylvania
E
Elizabeth Browning
Executive Vice President, Marketing
Greater Philadelphia Area
E
Edward Russell
Director Human Resources
Greater Philadelphia Area
B
Barry Hess
Facility Supervisor
Philadelphia, Pennsylvania

Companies, you might be interested in:

FibroGen, Inc.
Fibroheal Woundcare Pvt Ltd
Fibromyalgia & Fatigue Centers, Inc.
Fibrose kystique Québec
The most popular email templates:
Fibrocell Science’s email formatsPercentage
firstNamelastNameInitialjaned@fibrocell.com85%
firstName.lastNamejane.doe@fibrocell.com82%
firstName_lastNamejane_doe@fibrocell.com58%
lastName.firstNamedoe.jane@fibrocell.com55%
lastName_firstNamedoe_jane@fibrocell.com56%
firstNameInitial_lastNameInitialj_d@fibrocell.com44%

Our Integration Partners

+ 13 more